India ranked number three in manufacturing drugs across the world. One in every 2 tablets taken by any patient in the world is manufactured by the Indian pharmaceutical industry, one in every 2 vaccines administered is manufactured in the country, and India supplies 40 percent of generic drugs. So, in India, the demand for generic medicine is increasing day by day at a global level, making it one of the potential suppliers of generic medicine. India Generic Drugs market stood at USD 24.53 Billion in 2022 and is expected to grow at a steady CAGR of 6.97% during the forecast period.
Ikris Pharma Network was founded by Mr. Praveen Sikri in the year 2014 and is NOIDA based
pharmaceutical company. It is one of the most reliable pharmaceutical companies which deals with generic medication supplies. This made it the key player in the industry.
We are internationally recognized and specialize in pharmaceutical wholesale and supply. Over the years, Ikris Pharma has built an efficient network successfully and is the only company to have pan India presence certified by GDP and ISO under WHO Guidelines.
We, as generic medicine suppliers, have relevant experiences and services which make us stand out of the queue. Ikris Pharma Network has access to various treatments for rare diseases, heart disease, cancer, and HIV. Apart from that, we are equivalently into every latest medicine as well as Brands and their generic equivalents for our customers/patients.
We are an international wholesaler and exporter of US/EMEA/ other FDA-approved pharmaceuticals and biopharmaceuticals. Ikris Pharma supplies brand name, generic, and OTC (over-the-counter) US/EMEA/ other FDA products to domestic and international health care organizations, hospitals, Government, Pharmaceutical companies, CROs, pharmacies, and other licensed wholesalers.
We have chains in generic medication exports in more than 100 countries. Till now, we have served more than 50000+ patients across 150+ countries, including Africa, the United States, the UK, Gulf countries, Vietnam, Sri Lanka, South East Asia, the Philippines, Cambodia, Poland, and many more.
According to a report- The pharmaceutical industry in India is expected to reach $65 billion by 2024 and $130 billion by 2030. The Indian pharmaceutical industry is currently valued at $50 billion. India is a significant exporter country of Pharmaceuticals, with over 200+ countries served by Indian pharma exports.
Praveen Sikri, CEO of Ikris Pharma Network, says: “India is the largest producer of Generic Medicine in the world. There are more than 10500 manufacturing companies in India. There are more than 665 USA FDA-approved manufacturing plants in India, which is the highest number outside the USA. This reflects the qualitative aspect of Indian Generic Medicines. Indian Pharmaceutical companies have the capacity and capability to produce Quality generic medicine at an economical price. The Indian Government has provided a favorable environment for FDI in the Pharmaceutical Sector.